title: Hyperventilation and asymptomatic chronic asthma.
abstract: BACKGROUND
  We have consistently argued that mild asthma is an important underlying aetiological factor in patients with severe symptomatic hyperventilation. While hyperventilation has been demonstrated in acute asthma, there have been few studies in mild chronic asthma, and mechanisms are uncertain.
  
  
  METHODS
  Twenty three currently asymptomatic chronically asthmatic patients (occasional use of bronchodilators, normal lung function, hyperresponsive to methacholine) were studied and 17 matched normal subjects acted as controls. Ventilation, pattern of breathing, arterial carbon dioxide and oxygen tensions (PaCO(2), PaO(2)), end tidal PCO(2) (PETCO(2)), standard lung function, airway responsiveness to methacholine, airway inflammation assessed by eosinophils in induced sputum, and psychiatric morbidity (Spielberger STAI-Y and Beck Depression Inventory) were measured.
  
  
  RESULTS
  Despite the absence of current asthmatic symptoms, no clinical evidence of hyperventilation, and normal lung function in the patients with asthma, PaCO(2) and PETCO(2) were significantly (p<0.01) lower in the patients than in the control group (mean (SD) PaCO(2) 4.96 (0.43) kPa for patients versus 5.27 (0.38) kPa for controls (mean difference 0.31 kPa, 95% confidence interval (CI) 0.06 to 0.56, p<0.02)). PETCO(2) was very similar to PaCO(2) in both groups (mean (SD) PETCO(2) 4.89 (0.47) kPa for the patients and 5.28 (0.40) for the controls (mean difference 0.39 kPa, 95% CI 0.12 to 0.66, p<0.01)). There was no significant difference in ventilation or respiratory pattern between the two groups. The reduced PaCO(2) in the asthmatic patients correlated significantly with the concentration of methacholine provoking a fall in FEV(1) of more than 20% (PC(20)) (r = 0.56, p<0.01) but not with any aspect of lung function, eosinophil count, or anxiety/depression.
  
  
  CONCLUSIONS
  Mild asymptomatic asthma is not associated with clinically significant hyperventilation but is associated with a significant reduction in both arterial and end tidal PCO(2) which relates to airway hyperresponsiveness rather than to the degree of airway obstruction or mucosal inflammation. Anxiety and depression appear not to be implicated.
authors.affiliation: Department of Respiratory Medicine and Allergy, Guy's, King's and St Thomas' School of Medicine, King's Denmark Hill Campus, London SE5 9PJ, UK.
authors.forename: C A
authors.initials: CA
authors.lastname: Osborne
authors.forename: B J
authors.initials: BJ
authors.lastname: O'Connor
authors.forename: A
authors.initials: A
authors.lastname: Lewis
authors.forename: V
authors.initials: V
authors.lastname: Kanabar
authors.forename: W N
authors.initials: WN
authors.lastname: Gardner
mesh_terms: D000293:Adolescent; D000328:Adult; D001249:Asthma / Q000097:blood / Q000150:complications* / Q000503:physiopathology; D002245:Carbon Dioxide / Q000097:blood; D016022:Case-Control Studies; D002908:Chronic Disease; D005260:Female; D006801:Humans; D006985:Hyperventilation / Q000097:blood / Q000209:etiology*; D008297:Male; D010313:Partial Pressure; D015656:Respiratory Mechanics; D012720:Severity of Illness Index
chemical_list: D002245:Carbon Dioxide